NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Interventional Procedures Advisory Committee

Transcription

1 NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional Procedures Advisory Committee Minutes of the Committee s 172 nd meeting held at 10:30 on Thursday 09 th August 2018 at NICE, 10 Spring Gardens, London, SW1A 2BU. PRESENT: Dr Tom Clutton-Brock (Chair) Dr Wael Agur Mr Jonathan Anderson Mrs Sally Brearley Dr Andrew Cook (Vice Chair) Mr Mahmoud Elfar Dr Anthony Emmerson Mrs Suzanne Halliday Mrs Rosemary Harris Mr Anthony Hatswell Mr Colin Howie Mr Alistair Jenkins Dr Tim Kinnaird Mr Malcolm Lowe-lauri Dr Neil McGuire Miss Karen Nugent Professor Frank Smith Dr Dhiraj Tripathi In Attendance NICE Staff: Ms Ria Skelton - Senior Medical Editor Mrs Helen Gallo- Analyst, IPP Professor Kevin Harris - Programme Director Clinical Advisor, IPP Mr Azad Hussain Administrator, IPP Miss Chloe Kastoryano - Public Involvement Adviser, PIP Dr Ignacio Malagon Consultant Clinical Advisor, IPP Professor John Powell, Consultant Clinical Advisor, IPP Mrs Vassilia Verdiel - Analyst IPP Mrs Bijal Joshi, Programme Manager, IPP Specialist Advisors: Professor Prokar Dasgupta Specialist Advisor for IP1701 Dr Paul Crowe Specialist Advisor for IP891/2 Observers: Apologies: Gunveer Plahe Public Health Registrar Dr Shivali Fulchand - Academic Foundation Doctor Dr Zahida Adam Dr Nicholas Chalmers Mr Tim Jackson Dr James Tysome Dr Chris Carroll Mr Kieran Murphy 1

2 Dr Peter Murphy Note: The order in which the Committee took items of business at the meeting might differ from the agenda Meeting started: 10:33 Introduction to the meeting The Chairman welcomed the Committee Members and observers specifically Suzanne Halliday (Advanced Nurse Practitioner) and Karen Nugent (Colorectal Surgeon) as two new additions to the committee. The Chairman also introduced Dr Shivali Fulchand as a FY2 Doctor on her placement at NICE. The Chairman also welcomed the members of the public and company representatives present at the meeting. Code of conduct for members of the public and company representatives attending the meeting The Chairman outlined the code of conduct for the members of the public and company representatives attending the meeting. 1. Any Other Business The Chairman informed the Committee that Colin Howie, Wael Agur and Malcolm Lowe- Lauri will be leaving the meeting early. 2. Minutes of previous meeting Members accepted these as a correct record. 3. Matters arising None 4. Agenda changes The chairman informed the Committee that there will be changes to the agenda and now the order of the agenda will be IP1701, IP379/2, IP998/2, IP1690, IP1013/2, IP1103 and IP NICE s Advisory Body guide to declaring a conflict of interest The Chairman drew the Committee s attention to NICE s advisory body quick guide for declaring conflicts of interest. 6. Newly Notified Procedures 2

3 IP1701 Prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia The discussion on IP1701 Prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia started at 10:39 A company representative from Medi-Tate was present for this topic. Introduced by Prokar Dasgupta and Mahmoud Elfar The Chairman declared a Part Two and Prokar Dasgupta and members of the public as well as company representatives left the meeting at 11:11 The Committee made its provisional recommendations on the safety and efficacy of the procedure. The discussion on IP1701 Prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia ended at 11:23 The members of the public returned at 11:25. IP379/2 Laparoscopic cerclage for cervical incompetence to prevent late miscarriage or preterm birth The discussion on IP379/2 Laparoscopic cerclage for cervical incompetence to prevent late miscarriage or preterm birth started at 11:25 Dhiraj Tripathi declared a non-specific interest as Gore-tex suture is made by Gore Medical and Dhiraj received speaker fees from Gore Medical who also make this product. Dhiraj was allowed to stay for part two as this is unrelated to the product under consideration or the comparator Introduced by Mahmoud Elfar and Wael Agur The Chairman declared a Part Two and members of the public left the meeting at 11:54. The Committee made its provisional recommendations on the safety and efficacy of the procedure. The discussion on IP379/2 Laparoscopic cerclage for cervical incompetence to prevent late miscarriage or preterm birth ended at 12:20 3

4 7. Public Consultation comments IP998/2 Subcutaneous automated low-flow pump implantation for refractory ascites caused by cirrhosis The discussion on IP998/2 Subcutaneous automated low-flow pump implantation for refractory ascites caused by cirrhosis started at 13:01 A representative from Sequana Medical AG was present for this topic. Introduced by Dhiraj Tripathi The Committee considered the consultation comments The Chairman declared a Part Two and members of the public as well as company representatives left the meeting at 13:29 The Committee upheld its decision on the safety and efficacy of the procedure. The discussion on IP998/2 Subcutaneous automated low-flow pump implantation for refractory ascites caused by cirrhosis ended at 13:31 The members of the public as well as company representatives returned to the meeting at 13:32 IP1690 Ex-vivo machine perfusion for extracorporeal preservation of livers for transplantation The discussion on IP1690 Ex-vivo machine perfusion for extracorporeal preservation of livers for transplantation started at 13:35 Representatives from Organox and Organ Assist were present for this topic. Introduced by Dhiraj Tripathi The Committee considered the consultation comments The Chairman declared a Part Two and members of the public as well as company representatives left the meeting at 13:50 The Committee upheld its decision on the safety and efficacy of the procedure. 4

5 The discussion on IP1690 Ex-vivo machine perfusion for extracorporeal preservation of livers for transplantation ended at 13:52 The members of the public returned at 14:11 8. Briefs of procedures for future assessment IP1103 Functional Electrical Stimulation to stimulate muscle recovery in chronic disease The discussion on IP1103 Functional Electrical Stimulation to stimulate muscle recovery in chronic disease started at 14:11 The Chair reminded the committee that the equalities and diversity section is in the brief and should be reviewed and commented on as necessary by all the Committee. Introduced by Alistair Jenkins The Committee advised on the content of the brief for evaluation of this procedure. The discussion on IP1103 Functional Electrical Stimulation to stimulate muscle recovery in chronic disease ended at 14:18 9. Newly Notified Procedures IP891/2 Percutaneous venoplasty for chronic cerebrospinal venous insufficiency in Multiple Sclerosis The discussion on IP891/2 Percutaneous venoplasty for chronic cerebrospinal venous insufficiency in Multiple Sclerosis started at 14:18 Introduced by Frank Smith and Paul Crowe The Chairman declared a Part Two and Dr Paul Crowe and member of the public left the meeting at 14:40 The Committee made its provisional recommendations on the safety and efficacy of the procedure. The discussion on IP891/2 Percutaneous venoplasty for chronic cerebrospinal venous insufficiency in Multiple Sclerosis ended at 14: Briefs 5

6 IP1013/2 Transcatheter valve-in-valve implantation for aortic bioprosthetic valve dysfunction The discussion on IP1013/2 Transcatheter valve-in-valve implantation for aortic bioprosthetic valve dysfunction started at 14:48 The Chair reminded the committee that the equalities and diversity section is in the brief and should be reviewed and commented on as necessary by all the Committee. Introduced by Tim Kinnaird The Committee advised on the content of the brief for evaluation of this procedure. The discussion on IP1013/2 Transcatheter valve-in-valve implantation for aortic bioprosthetic valve dysfunction ended at 15:31 IP1719 Bronchoscopic steam ablation for upper-lobe emphysema The discussion on IP1719 Bronchoscopic steam ablation for upper-lobe emphysema started at 15:32 The Chair reminded the committee that the equalities and diversity section is in the brief and should be reviewed and commented on as necessary by all the Committee. Introduced by Jon Anderson The Committee advised on the content of the brief for evaluation of this procedure. The discussion on IP1719 Bronchoscopic steam ablation for upper-lobe emphysema ended at 16:11 9. Other meeting matters The Chairman discussed the Non-Staff Reimbursement Policy Date of the next meeting The 173 rd meeting of the Interventional Procedures Advisory Committee will be held on Thursday 13 th September 2018, and will start promptly at The meeting will be held at NICE, 10 Spring Garden, London, SW1A 2BU The meeting ended at 16:15 6